Article Details

Aclaris Acquires Global Rights to Biosion's Immunology Assets in $940M+ Deal | ACRS Stock News

Retrieved on: 2024-11-18 14:00:36

Tags for this article:

Click the tags to see associated articles and topics

Aclaris Acquires Global Rights to Biosion's Immunology Assets in $940M+ Deal | ACRS Stock News. View article details on hiswai:

Excerpt

... monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates. Biosion operates across the US, China , and Australia . Learn more at ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up